Title: 2025-2026 Regular Session HB 928 PN 0992 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN0992
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HB 928 PN 0992 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 992 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.928 Session of 2025 INTRODUCED BY KOSIEROWSKI, MARCELL, VENKAT, SANCHEZ, WAXMAN, GUENST, BURGOS, MADDEN, DEASY, HANBIDGE, HILL-EVANS, OTTEN, KENYATTA, HADDOCK, MAYES, BOYD, CURRY, CERRATO, DONAHUE, BOROWSKI, McNEILL, SCHLOSSBERG, MIHALEK, O'MARA, WEBSTER, CIRESI, WARREN, ISAACSON, FREEMAN, SHUSTERMAN, CEPEDA-FREYTIZ, GIRAL, PIELLI, STEELE, HOWARD, DALEY AND MALAGARI, MARCH 17, 2025 REFERRED TO COMMITTEE ON CHILDREN AND YOUTH, MARCH 17, 2025 AN ACTAmending Title 35 (Health and Safety) of the Pennsylvania Consolidated Statutes, in epinephrine auto-injector entities, further providing for definitions and for epinephrine auto-injectors for authorized entities.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The definitions of "authorized entity" and "epinephrine auto-injector" in section 5502 of Title 35 of the Pennsylvania Consolidated Statutes are amended to read:§ 5502. Definitions.The following words and phrases when used in this chapter shall have the meanings given to them in this section unless the context clearly indicates otherwise:* * *"Authorized entity." Any entity or organization, other than a school entity or a nonpublic school under section 1414.2 of 12345678910111213141516 the act of March 10, 1949 (P.L.30, No.14), known as the Public School Code of 1949, which has an employee or agent who has completed the required training and at which allergens capable of causing anaphylaxis may be present, including, but not limited to:(1) recreation camps;(2) colleges and universities;[(3) day-care facilities;](4) youth sports leagues;(5) amusement parks;(6) restaurants;(7) places of employment;(8) sports arenas; and(9) law enforcement agencies.* * *"Epinephrine auto-injector." A single-use device used for the automatic injection of a premeasured appropriate weight-based dose of epinephrine into the human body.* * *Section 2. Section 5503 of Title 35 is amended to read:§ 5503. Epinephrine auto-injectors for authorized entities and day-care facilities.(a) Prescribing and dispensing.--Notwithstanding any provision of law to the contrary, a health care practitioner with prescriptive authority may prescribe epinephrine auto-injectors in the name of an authorized entity or day-care facility for use in accordance with this section. Pharmacists and health care practitioners may dispense epinephrine auto-injectors pursuant to a prescription issued in the name of an authorized entity or day-care facility.20250HB0928PN0992 - 2 - 123456789101112131415161718192021222324252627282930 (b) Supply.--[(1)] An authorized entity may acquire and stock a supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this section. [The epinephrine auto-injectors shall be stored:(i) in a location readily accessible in an emergency; and(ii) in accordance with:(A) the epinephrine auto-injector's instructions for use; and(B) any additional requirements that may be established by the department.(2) An authorized entity shall designate employees or agents who have completed the training required under subsection (d) to be responsible for the storage, maintenance, control and general oversight of epinephrine auto-injectors acquired by the authorized entity.] A day-care facility shall, subject to the availability of funding by the department, acquire and stock a supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this section.(b.1) Storage.--(1) An epinephrine auto-injector shall be stored:(i) in a location readily accessible in an emergency; and(ii) in accordance with:(A) the epinephrine auto-injector's instructions for use; and(B) any additional requirements that may be established by the department.20250HB0928PN0992 - 3 - 123456789101112131415161718192021222324252627282930 (2) An authorized entity or day-care facility shall designate an employee or agent who has completed the required training under subsection (d) to be responsible for the storage, maintenance, control and general oversight of epinephrine auto-injectors acquired by the authorized entity or day-care facility.(c) Use.--An employee or agent of an authorized entity or other individual associated with the entity or day-care facility who has completed the training required under subsection (d) may use epinephrine auto-injectors prescribed under subsection (a) to do any of the following:(1) Provide an epinephrine auto-injector for immediate administration to any individual, or the parent, guardian or caregiver of the individual, who the employee, agent or other individual associated with the entity believes, in good faith, is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine auto-injector or has previously been diagnosed with an allergy.(2) Administer an epinephrine auto-injector to any individual who the employee, agent or other individual believes, in good faith, is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine auto-injector or has previously been diagnosed with an allergy.(d) Training.--(1) An employee or agent of the authorized entity or other individual associated with the entity or day-care facility shall complete an anaphylaxis training program as required by the department. The training shall be conducted by a nationally recognized organization experienced in 20250HB0928PN0992 - 4 - 123456789101112131415161718192021222324252627282930 training laypersons in emergency health treatment, a health care practitioner employed or contracted by the authorized entity or day-care facility, or an entity or individual approved by the department. The department may approve specific entities or individuals or may approve classes of entities or individuals to conduct the training. Training may be conducted online or in person and, at a minimum, shall cover:(i) how to recognize signs and symptoms of severe allergic reactions, including anaphylaxis;(ii) standards and procedures for the storage and administration of an epinephrine auto-injector; and(iii) emergency follow-up procedures.(2) The entity or individual that conducts the training shall issue a certificate, on a form developed or approved by the department, to each individual who successfully completes the anaphylaxis training program.(d.1) Informational materials for day-care facilities.--The department, in consultation with the Department of Human Services, shall develop, within 90 days of the effective date of this subsection, informational materials for a day-care facility to distribute to a parent or guardian of a child in the facility's care. The following shall apply:(1) The materials shall include the following:(i) Signs and symptoms of allergic reactions, including anaphylaxis.(ii) The requirements under subsections (a), (b), (b.1), (c) and (d).(iii) If an incident involving an allergic reaction occurs, any emergency treatment procedures to be followed 20250HB0928PN0992 - 5 - 123456789101112131415161718192021222324252627282930 by facility staff.(iv) Any food allergy policy the center has in place, including implementation of a plan specific to a child.(2) The department shall update the informational materials on a triennial basis.(3) A day-care facility shall provide the informational materials to a parent or guardian of a child in its care on an annual basis.(e) Good Samaritan protections.--(1) The following shall not be liable for any injuries or related damages that result from any act or omission taken under this section:(i) An authorized entity or day-care facility that possesses and makes available epinephrine auto-injectors and its employees, agents and other individuals associated with the entity;(ii) a health care practitioner that prescribes or dispenses epinephrine auto-injectors to an authorized entity or day-care facility;(iii) a pharmacist or health care practitioner that dispenses epinephrine auto-injectors to an authorized entity or day-care facility; and(iv) an individual or entity that conducts the training described under subsection (d).(2) The immunity provided under paragraph (1) shall not apply to acts or omissions constituting intentional misconduct or gross negligence.(3) The administration of an epinephrine auto-injector in accordance with this section shall not be considered the 20250HB0928PN0992 - 6 - 123456789101112131415161718192021222324252627282930 practice of medicine or any other profession that otherwise requires licensure.(4) This subsection shall not eliminate, limit or reduce any other immunity or defense that may be available under law, including that provided under 42 Pa.C.S. § 8332 (relating to emergency response provider and bystander good Samaritan civil immunity).(5) An entity located in this Commonwealth shall not be liable for any injuries or related damages that result from the provision or administration of an epinephrine auto-injector outside of this Commonwealth if the entity:(i) would not have been liable for the injuries or related damages had the provision or administration occurred within this Commonwealth; or(ii) is not liable for the injuries or related damages under the law of the state in which the provision or administration occurred.Section 3. This act shall take effect in 60 days.20250HB0928PN0992 - 7 - 123456789101112131415161718


================================================================================

Raw Text:
2025-2026 Regular Session HB 928 PN 0992 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 992 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.928 Session of 2025 INTRODUCED BY KOSIEROWSKI, MARCELL, VENKAT, SANCHEZ, WAXMAN, GUENST, BURGOS, MADDEN, DEASY, HANBIDGE, HILL-EVANS, OTTEN, KENYATTA, HADDOCK, MAYES, BOYD, CURRY, CERRATO, DONAHUE, BOROWSKI, McNEILL, SCHLOSSBERG, MIHALEK, O'MARA, WEBSTER, CIRESI, WARREN, ISAACSON, FREEMAN, SHUSTERMAN, CEPEDA-FREYTIZ, GIRAL, PIELLI, STEELE, HOWARD, DALEY AND MALAGARI, MARCH 17, 2025 REFERRED TO COMMITTEE ON CHILDREN AND YOUTH, MARCH 17, 2025 AN ACTAmending Title 35 (Health and Safety) of the Pennsylvania Consolidated Statutes, in epinephrine auto-injector entities, further providing for definitions and for epinephrine auto-injectors for authorized entities.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The definitions of "authorized entity" and "epinephrine auto-injector" in section 5502 of Title 35 of the Pennsylvania Consolidated Statutes are amended to read:§ 5502. Definitions.The following words and phrases when used in this chapter shall have the meanings given to them in this section unless the context clearly indicates otherwise:* * *"Authorized entity." Any entity or organization, other than a school entity or a nonpublic school under section 1414.2 of 12345678910111213141516 the act of March 10, 1949 (P.L.30, No.14), known as the Public School Code of 1949, which has an employee or agent who has completed the required training and at which allergens capable of causing anaphylaxis may be present, including, but not limited to:(1) recreation camps;(2) colleges and universities;[(3) day-care facilities;](4) youth sports leagues;(5) amusement parks;(6) restaurants;(7) places of employment;(8) sports arenas; and(9) law enforcement agencies.* * *"Epinephrine auto-injector." A single-use device used for the automatic injection of a premeasured appropriate weight-based dose of epinephrine into the human body.* * *Section 2. Section 5503 of Title 35 is amended to read:§ 5503. Epinephrine auto-injectors for authorized entities and day-care facilities.(a) Prescribing and dispensing.--Notwithstanding any provision of law to the contrary, a health care practitioner with prescriptive authority may prescribe epinephrine auto-injectors in the name of an authorized entity or day-care facility for use in accordance with this section. Pharmacists and health care practitioners may dispense epinephrine auto-injectors pursuant to a prescription issued in the name of an authorized entity or day-care facility.20250HB0928PN0992 - 2 - 123456789101112131415161718192021222324252627282930 (b) Supply.--[(1)] An authorized entity may acquire and stock a supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this section. [The epinephrine auto-injectors shall be stored:(i) in a location readily accessible in an emergency; and(ii) in accordance with:(A) the epinephrine auto-injector's instructions for use; and(B) any additional requirements that may be established by the department.(2) An authorized entity shall designate employees or agents who have completed the training required under subsection (d) to be responsible for the storage, maintenance, control and general oversight of epinephrine auto-injectors acquired by the authorized entity.] A day-care facility shall, subject to the availability of funding by the department, acquire and stock a supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this section.(b.1) Storage.--(1) An epinephrine auto-injector shall be stored:(i) in a location readily accessible in an emergency; and(ii) in accordance with:(A) the epinephrine auto-injector's instructions for use; and(B) any additional requirements that may be established by the department.20250HB0928PN0992 - 3 - 123456789101112131415161718192021222324252627282930 (2) An authorized entity or day-care facility shall designate an employee or agent who has completed the required training under subsection (d) to be responsible for the storage, maintenance, control and general oversight of epinephrine auto-injectors acquired by the authorized entity or day-care facility.(c) Use.--An employee or agent of an authorized entity or other individual associated with the entity or day-care facility who has completed the training required under subsection (d) may use epinephrine auto-injectors prescribed under subsection (a) to do any of the following:(1) Provide an epinephrine auto-injector for immediate administration to any individual, or the parent, guardian or caregiver of the individual, who the employee, agent or other individual associated with the entity believes, in good faith, is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine auto-injector or has previously been diagnosed with an allergy.(2) Administer an epinephrine auto-injector to any individual who the employee, agent or other individual believes, in good faith, is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine auto-injector or has previously been diagnosed with an allergy.(d) Training.--(1) An employee or agent of the authorized entity or other individual associated with the entity or day-care facility shall complete an anaphylaxis training program as required by the department. The training shall be conducted by a nationally recognized organization experienced in 20250HB0928PN0992 - 4 - 123456789101112131415161718192021222324252627282930 training laypersons in emergency health treatment, a health care practitioner employed or contracted by the authorized entity or day-care facility, or an entity or individual approved by the department. The department may approve specific entities or individuals or may approve classes of entities or individuals to conduct the training. Training may be conducted online or in person and, at a minimum, shall cover:(i) how to recognize signs and symptoms of severe allergic reactions, including anaphylaxis;(ii) standards and procedures for the storage and administration of an epinephrine auto-injector; and(iii) emergency follow-up procedures.(2) The entity or individual that conducts the training shall issue a certificate, on a form developed or approved by the department, to each individual who successfully completes the anaphylaxis training program.(d.1) Informational materials for day-care facilities.--The department, in consultation with the Department of Human Services, shall develop, within 90 days of the effective date of this subsection, informational materials for a day-care facility to distribute to a parent or guardian of a child in the facility's care. The following shall apply:(1) The materials shall include the following:(i) Signs and symptoms of allergic reactions, including anaphylaxis.(ii) The requirements under subsections (a), (b), (b.1), (c) and (d).(iii) If an incident involving an allergic reaction occurs, any emergency treatment procedures to be followed 20250HB0928PN0992 - 5 - 123456789101112131415161718192021222324252627282930 by facility staff.(iv) Any food allergy policy the center has in place, including implementation of a plan specific to a child.(2) The department shall update the informational materials on a triennial basis.(3) A day-care facility shall provide the informational materials to a parent or guardian of a child in its care on an annual basis.(e) Good Samaritan protections.--(1) The following shall not be liable for any injuries or related damages that result from any act or omission taken under this section:(i) An authorized entity or day-care facility that possesses and makes available epinephrine auto-injectors and its employees, agents and other individuals associated with the entity;(ii) a health care practitioner that prescribes or dispenses epinephrine auto-injectors to an authorized entity or day-care facility;(iii) a pharmacist or health care practitioner that dispenses epinephrine auto-injectors to an authorized entity or day-care facility; and(iv) an individual or entity that conducts the training described under subsection (d).(2) The immunity provided under paragraph (1) shall not apply to acts or omissions constituting intentional misconduct or gross negligence.(3) The administration of an epinephrine auto-injector in accordance with this section shall not be considered the 20250HB0928PN0992 - 6 - 123456789101112131415161718192021222324252627282930 practice of medicine or any other profession that otherwise requires licensure.(4) This subsection shall not eliminate, limit or reduce any other immunity or defense that may be available under law, including that provided under 42 Pa.C.S. § 8332 (relating to emergency response provider and bystander good Samaritan civil immunity).(5) An entity located in this Commonwealth shall not be liable for any injuries or related damages that result from the provision or administration of an epinephrine auto-injector outside of this Commonwealth if the entity:(i) would not have been liable for the injuries or related damages had the provision or administration occurred within this Commonwealth; or(ii) is not liable for the injuries or related damages under the law of the state in which the provision or administration occurred.Section 3. This act shall take effect in 60 days.20250HB0928PN0992 - 7 - 123456789101112131415161718